Leinco Technologies, a leader in antibody and protein development, is thrilled to announce that it has been awarded a $1 M ...

The prognostic test stratifies hospitalized women with hypertensive disorders of pregnancy into low- and high-risk categories for developing severe preeclampsia.

Nuclera’s Key Account Manager shares how their eProtein Discovery system is propelling rapid recombinant protein optimization and its utilization in drug discovery.

EV Resources has confirmed high-grade antimony samples from first assays at its newest potential near-term production asset Los Lirios in Oaxaca, Mexico.

The Korea Research Institute of Standards and Science (KRISS) has developed a safety evaluation technology for nanoparticles* ...

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

Cubit Diagnostics announced on Tuesday that it has been awarded $2.6 million by the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) Tech program. The funding will enable the ...

Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, today announced the full commercial launch of its EpiPlex™ platform, the first to concurrently detect and quantify multiple RNA ...

Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® DILI assay kit: Human 24.

Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...

A team of biomolecular engineers, pathologists, and internal medicine specialists at the University of Texas Medical Branch, ...